Dr. Moy has completed extensive training, including a postdoctoral fellowship at the Tavazoie Laboratory, Rockefeller University and a medical oncology fellowship at Memorial Sloan Kettering Cancer Center. His research is heavily focused on gastrointestinal cancers, with numerous contributions to understanding metastatic liver colonization in colorectal cancer and developing innovative cancer therapies.
Dr. Moy has received several prestigious awards, including the Louis V. Gerstner Scholar Award and the Damon Runyon Cancer Research Foundation Robert Black Fellow Award. He actively participates in academic service and leadership, including roles on the HICCC Data Safety and Monitoring Committee and co-chair of the HICCC CGE Clinical Research Taskforce. In 2023 he was also announced as a recipient of the American Association for Cancer Research (AACR)-Debbie’s Dream Foundation Innovation and Discovery Grant.
An active member of several professional organizations, including the AACR and the American Society of Clinical Oncology, Dr. Moy also contributes to peer-reviewed journals and reviews Discover Oncology, Cancers, and The Oncologist. His work has led to significant funding from institutions like the NIH, the Gastric Cancer Foundation, and the Department of Defense.
Dr. Moy’s dedication to cancer research and education is evident in his prolific publication record, mentorship of future medical professionals, and involvement in numerous clinical trials aimed at improving outcomes for patients with gastrointestinal cancers.